Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US OptionsDetailed Quotes
RGEN250516C130000
- 17.90
- 0.000.00%
15min DelayClose Apr 29 16:00 ET
0.00High0.00Low
17.90Open17.90Pre Close0 Volume10 Open Interest130.00Strike Price0.00Turnover64.27%IV6.07%PremiumMay 16, 2025Expiry Date9.43Intrinsic Value100Multiplier16DDays to Expiry8.47Extrinsic Value100Contract SizeAmericanOptions Type0.7241Delta0.0176Gamma10.60Leverage Ratio-0.2054Theta0.0396Rho7.68Eff Leverage0.0990Vega
Repligen Newsroom
JP Morgan Maintains Overweight on Repligen, Lowers Price Target to $190
Repligen Analyst Ratings
William Blair Maintains Repligen(RGEN.US) With Buy Rating
Craig-Hallum Maintains Repligen(RGEN.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY), Ironwood Pharma (IRWD) and Repligen (RGEN)
Leerink Partners Sticks to Their Buy Rating for Repligen (RGEN)
CCORF Maintains Repligen(RGEN.US) With Hold Rating, Cuts Target Price to $150
Repligen Price Target Cut to $150.00/Share From $170.00 by Canaccord Genuity
Repligen Is Maintained at Hold by Canaccord Genuity
Repligen Analyst Ratings
Repligen (RGEN) Gets a Hold From Guggenheim
RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $202
RBC Capital Remains a Buy on Repligen (RGEN)
Evercore Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $155
Repligen Initiated at In-Line by Evercore ISI Group
Repligen Analyst Ratings
Evercore Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $155
William Blair Maintains Repligen(RGEN.US) With Buy Rating
Repligen's Strategic Acquisition of 908 Devices' Assets: A Buy Rating for Long-term Shareholder Value
CCORF Downgrades Repligen(RGEN.US) to Hold Rating, Maintains Target Price $170
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
